
Investing.com – Denmark stocks were lower after the close on Monday, as losses in the Chemicals, Real Estate and Healthcare sectors led shares lower.
At the close in Copenhagen, the OMX Copenhagen 20 fell 0.42%.
The best performers of the session on the OMX Copenhagen 20 were Jyske Bank A/S (CSE:JYSK), which rose 1.98% or 8.40 points to trade at 431.60 at the close. Meanwhile, Vestas Wind Systems A/S (CSE:VWS) added 1.66% or 3.22 points to end at 196.80 and Novozymes A/S B (CSE:NZYMb) was up 1.65% or 5.80 points to 358.30 in late trade.
The worst performers of the session were Coloplast A/S (CSE:COLOb), which fell 2.25% or 18.80 points to trade at 817.20 at the close. Novo Nordisk A/S Class B (CSE:NOVOb) declined 1.26% or 11.70 points to end at 916.00 and Genmab (CSE:GMAB) was down 0.62% or 19.00 points to 3,034.00.
Falling stocks outnumbered advancing ones on the Copenhagen Stock Exchange by 90 to 61 and 18 ended unchanged.
Crude oil for February delivery was up 1.73% or 1.29 to $75.75 a barrel. Elsewhere in commodities trading, Brent oil for delivery in February rose 1.42% or 1.12 to hit $80.16 a barrel, while the February Gold Futures contract fell 0.17% or 3.15 to trade at $1,797.05 a troy ounce.
USD/DKK was down 0.19% to 7.01, while EUR/DKK unchanged 0.06% to 7.44.
The US Dollar Index Futures was down 0.03% at 104.30.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.